Biomedical Bonding AB appoints Evelina Mikaelson as new CEO
Biomedical Bonding announces today that Evelina Mikaelson has been appointed new CEO effective January 1[st], 2023. This strategic appointment follows a comprehensive search process initiated after the founder and CEO Professor Michael Malkochs decision to step down as CEO as the company enters a more expansive commercial phase.Biomedical Bonding AB is establishing a new paradigm in bone fracture fixation and restoration surgery based on its technological platform Bonevolent™ - bone-like medical adhesives and composite implants. Bonevolent™ products provide surgeons with unprecedented